JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB2739

Anti-O-Linked N-Acetylglucosamine 抗体 [RL2]

Anti-O-Linked N-Acetylglucosamine antibody [RL2]

5

(18 Reviews)

|

(246 Publications)

Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab2739) is a mouse monoclonal antibody detecting O-Linked N-Acetylglucosamine in Western Blot, ICC/IF. Suitable for Human, Rat.

- Over 180 publications
- Trusted since 2003
4 Images
Immunocytochemistry/ Immunofluorescence - Anti-O-Linked N-Acetylglucosamine antibody [RL2] (AB2739)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-O-Linked N-Acetylglucosamine antibody [RL2] (AB2739)

ab2739 stained in MCF7 cells. Cells were fixed with 4% paraformaldehyde (10min) at room temperature and incubated with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% triton for 1h at room temperature to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab2739 at 5μg/ml and ab6046 (Rabbit polyclonal to beta Tubulin - Loading Control) at 1/1000 dilution overnight at +4°C. The secondary antibodies were ab150080 (pseudo-colored red) and ab150117 (colored green) used at 1 ug/ml for 1hour at room temperature. DAPI was used to stain the cell nuclei (colored blue) at a concentration of 1.43μM for 1hour at room temperature.

Western blot - Anti-O-Linked N-Acetylglucosamine antibody [RL2] (AB2739)
  • WB

Lab

Western blot - Anti-O-Linked N-Acetylglucosamine antibody [RL2] (AB2739)

Jurkat cells were treated with either 50 uM PugNAc (ab144670) or 4 mM glucosamine + 50 uM PugNAc (ab144670) for three hours prior to harvest to stimulate O-linked glycosylation. The expected increase in glycosylation is observed in the treated lanes 2 & 4.

All lanes:

Western blot - Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab2739) at 1 µg/mL

Lanes 1 and 3:

Jurkat cells treated with 0 uM PugNAc at 20 µg

Lane 2:

Jurkat cells treated with 50 uM PugNAc (3 hours) at 20 µg

Lane 4:

Jurkat cells treated with 4 mM glucosamine and 50 uM PugNAc (3 hours) at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/50000 dilution

true

Exposure time: 12min

Western blot - Anti-O-Linked N-Acetylglucosamine antibody [RL2] (AB2739)
  • WB

Project

Western blot - Anti-O-Linked N-Acetylglucosamine antibody [RL2] (AB2739)

The antibody was tested against the immunogen (isolated rat liver nuclear envelopes, which contain 8 O-linked glycoproteins in the nuclear pore complex).

All lanes:

Western blot - Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab2739) at 1 µg/mL

All lanes:

Rat Liver Nuclear Envelope at 10 µg

Secondary

All lanes:

Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

true

Exposure time: 1min

Western blot - Anti-O-Linked N-Acetylglucosamine antibody [RL2] (AB2739)
  • WB

AbReview42315****

Western blot - Anti-O-Linked N-Acetylglucosamine antibody [RL2] (AB2739)

All lanes:

Western blot - Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab2739) at 1/3000 dilution

Lane 1:

Human neuroblastoma (SH-SY5Y) whole cell lysate - treated with 50µM z-Pugnac for 24 hours at 20 µg

Lane 2:

Human neuroblastoma (SH-SY5Y) whole cell lysate - untreated at 20 µg

Secondary

All lanes:

HRP-conjugated horse anti-mouse IgG polyclonal

true

Exposure time: 30s

This image is courtesy of an anonymous Abreview

不同偶联物与剂型 (4)

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-O-Linked N-Acetylglucosamine antibody [RL2]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-O-Linked N-Acetylglucosamine antibody [RL2]

  • HRP

    HRP Anti-O-Linked N-Acetylglucosamine antibody [RL2]

  • Carrier free

    Anti-O-Linked N-Acetylglucosamine antibody [RL2] - BSA and Azide free

关键信息

宿主种属

Mouse

克隆

Monoclonal

克隆号

RL2

亚型

IgG1

轻链类型

kappa

不含载体蛋白

No

反应种属

Rat, Human

应用

WB, ICC/IF

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "5-10 µg/mL", "ICCIF-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

产品详情

This antibody clone [RL2] is manufactured by Abcam.

If you require this antibody in a particular buffer formulation or a particular conjugate for your experiments, please contact orders@abcam.com or you can find further information here.

Product Specifications
Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab2739) is a mouse monoclonal antibody and is validated for use in ICC/IF, WB in human, rat samples.
Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab2739) specifically detects O-Linked N-Acetylglucosamine (UniProt ID: ; Molecular weight: kDa) and is sold in 100 µg selling sizes.

Quality and Validation
Abcam's high quality validation processes ensure Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab2739) has high sensitivity and specificity.
Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab2739) has been cited over 186 times in peer reviewed journals and is trusted by the scientific community.
Anti-O-Linked N-Acetylglucosamine antibody [RL2] (ab2739) has 17 independent reviews from customers.

Related Products
Conjugation-ready, carrier free format available for antibody clone RL2 - ab288303.
Antibody clone RL2 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, HRP (ab201993, ab201994, ab201995).

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification
存储溶液
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 6.97% L-Arginine
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

O-Linked N-Acetylglucosamine (O-GlcNAc) is a post-translational modification involving the addition of a single N-acetylglucosamine moiety to the serine or threonine residues of nuclear and cytoplasmic proteins. This dynamic modification is sometimes referred to as O-GlcNAcylation. The molecular mass of the O-GlcNAc group itself is approximately 203 Da. This modification is expressed widely across various tissues notably in the brain and pancreas. O-GlcNAc plays a critical role in regulating protein function stability and interaction.
Biological function summary

O-GlcNAc modifies proteins influencing cellular processes such as transcription signal transduction and stress response. It is involved in the regulation of transcription factors like Sp1 and NF-kB and is associated with the O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) enzymes which respectively add and remove the GlcNAc group. O-GlcNAc functions in a manner similar to phosphorylation often competing with it on the same or adjacent serine/threonine sites. This modification is not part of a permanent protein complex but dynamically modulates protein interactions and activity.

Pathways

This modification plays a fundamental role in pathways related to nutrient sensing and insulin signaling. It modulates proteins such as insulin receptor substrate 1 (IRS1) and Akt to link nutrient status to cellular responses. The hexosamine biosynthetic pathway (HBP) is an important pathway in which O-GlcNAc is synthesized. Through these pathways it impacts cellular signaling and metabolism influencing processes like cellular growth and apoptosis.

O-GlcNAc modification connects to conditions like diabetes and Alzheimer's disease. Elevated O-GlcNAc levels contribute to insulin resistance a hallmark of type 2 diabetes through interaction with proteins such as IRS1 and Akt. In Alzheimer's O-GlcNAc modifies tau protein reducing its phosphorylation and aggregation therefore potentially affecting neurofibrillary tangle formation. These connections underline the importance of O-GlcNAc in the pathophysiology of these diseases and highlight its potential as a therapeutic target.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

文献 (246)

Recent publications for all applications. Explore the full list and refine your search

Molecular therapy. Oncology 33:201046 PubMed41018975

2025

Epigenetic co-regulator HCF-1 promotes lung cancer via O-GlcNAcylation-dependent pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Priyanka P Srivastava,Abhilash Dasari,Saran Kumar,Ishaan Gupta,Deepali Jain,Shilpi Minocha

International journal of molecular sciences 26: PubMed40806239

2025

Integrated Transcriptome and Metabolome Analyses Uncover Cholesterol-Responsive Gene Networks.

Applications

Unspecified application

Species

Unspecified reactive species

Ruihao Zhang,Qi Sun,Lixia Huang,Jian Li

Open life sciences 20:20251109 PubMed40771411

2025

Artesunate inhibits hepatocellular carcinoma cell migration and invasion through OGA-mediated -GlcNAcylation of ZEB1.

Applications

Unspecified application

Species

Unspecified reactive species

Ying Li,Yuan Zhang,Wei Lu,Yun Chen,Xiaoling Qian

Research (Washington, D.C.) 8:0809 PubMed40740652

2025

Combinational Analysis of Metabolomic and O-GlcNAcylation Omics Reveals the HBP Metabolic Regulation of Chemoresistance via GFPT1/NR3C1 O-GlcNAcylation/GPX4 Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Xiang Zhou,Chunlin Zhang,Li Li,Zhenwei Feng,Xuesong Bai,Yuhua Mei,Weiyang He,Xin Gou,Xinyuan Li

Microbiology spectrum 13:e0052725 PubMed40719472

2025

O-GlcNAcylation at S659 enhances SARS-CoV-2 spike protein stability and pseudoparticle packaging efficiency.

Applications

Unspecified application

Species

Unspecified reactive species

Ting Xu,Jie Li,Xiaoxuan Lu,Shuai Song,Shengnan Wang,Jing Li,Leiliang Zhang

Nature communications 16:5959 PubMed40593803

2025

O-GlcNAcylation of FOXK1 co-opts BAP1 to orchestrate the E2F pathway and promotes oncogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Oumaima Ahmed,Louis Masclef,Nicholas Iannantuono,Jessica Gagnon,Mila Gushul-Leclaire,Karine Boulay,Benjamin Estavoyer,Mohamed Echbicheb,Kalidou Ali Boubacar,Marty Poy,Amina Boubekeur,Saad Menggad,Alejandro Schcolnik-Cabrera,Aurelio Balsalobre,Eric Bonneil,Pierre Thibault,Laura Hulea,Frédérick A Mallette,Jacques Drouin,Yoshiaki Tanaka,El Bachir Affar

Cancer cell international 25:236 PubMed40563096

2025

Integrated transcriptome analysis and combinatorial machine learning to construct a homeostatic model of acetylation for ccRCC and validate the key gene GCNT4.

Applications

Unspecified application

Species

Unspecified reactive species

Baohua Zhu,Ziyang Mo,Yi Bao,Xinxin Gan,Linhui Wang

International journal of molecular sciences 26: PubMed40508179

2025

Txnip/Trx Is a Potential Element in Regulating O-GlcNAc Modification in Photoreceptors to Alleviate Diabetic Retinopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Laraib Imdad,Shengnan Xu,Yulang Meng,Kaimin Bao,Wenkang Dong,Xuanya Yin,Yujie Tong,Wei Zhang,Xiang Ren,Li Kong

Cell death discovery 11:160 PubMed40204725

2025

O-GlcNAcylation of glutaminase isoform KGA inhibits ferroptosis through activation of glutaminolysis in hepatoblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Sijia Fang,Guoqing Zhu,Yi Xie,Miao Ding,Ni Zhen,Jiabei Zhu,Siwei Mao,Xiaochen Tang,Han Wu,Qi Zhang,Aijia Zhang,Xin Ni,Qiuhui Pan,Ji Ma

Proceedings of the National Academy of Sciences of the United States of America 122:e2410520122 PubMed40203037

2025

Perturbing nuclear glycosylation in the mouse preimplantation embryo slows down embryonic development.

Applications

Unspecified application

Species

Unspecified reactive species

Sara Formichetti,Joana B Serrano,Urvashi Chitnavis,Agnieszka Sadowska,Na Liu,Ana Boskovic,Matthieu Boulard
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com